Heron Therapeutics, Inc. · NASDAQ:HRTX
The Vanguard Group's stake in Heron Therapeutics, Inc. fell to 4.61% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group's stake in Heron Therapeutics, Inc. fell to 4.61%, 8,459,784 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).
- Stake
- 4.61%
- Shares
- 8,459,784
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.61% | 8,459,784 |
Source
Related
- Heron Therapeutics, Inc.
- The Vanguard Group
- Heron Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · The Vanguard Group · Jan 30, 2026
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026